SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: velociraptor_ who wrote (46589)2/4/2001 10:49:02 PM
From: Mike M  Read Replies (1) of 57584
 
One of my favorites is CRA...probably a bit overvalued as well, but they have already sequenced the human genome and are doing so much with it that they hold the potential to be one of the biggest databases for useful information which could be priceless.


CRA is also my favorite. It would seem to me to be the biotech equivalent of MSFT (I particularly like the CEO) with ABI the equivalent of INTC. Time will tell if that analogy fits or if promise gives way to disappointing results.

I was wondering if you do think CRA is overvalued, could you offer an analysis of valuation and price objectives like you did with CEGE? Is it possible that the promise is so great for this unique company that we have seen the lows? Thanks,

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext